Company Filing History:
Years Active: 2018
Title: Innovations of Shaoliang Li in Regenerative Medicine
Introduction
Shaoliang Li is an accomplished inventor based in Osaka, Japan. He has made significant contributions to the field of regenerative medicine through his innovative research and patents. His work focuses on developing materials that can enhance tissue engineering and regenerative therapies.
Latest Patents
One of Shaoliang Li's notable patents is titled "Modified laminin containing collagen binding molecule and use thereof." This patent describes a modified laminin characterized by a collagen binding molecule conjugated to specific sites on the laminin chains. The extracellular-matrix material developed from this modified laminin, along with collagen and/or gelatin, serves as an alternative to Matrigel. This innovation is particularly useful for creating safe three-dimensional tissue structures for regenerative medicine in humans. Shaoliang Li holds 1 patent in this area.
Career Highlights
Shaoliang Li is affiliated with Osaka University, where he conducts his research and development activities. His work has garnered attention for its potential applications in improving regenerative medicine techniques. His innovative approach to modifying laminin has opened new avenues for tissue engineering.
Collaborations
Shaoliang Li has collaborated with esteemed colleagues such as Kiyotoshi Sekiguchi and Ryoko Sato. These collaborations have further enriched his research and contributed to advancements in the field.
Conclusion
Shaoliang Li's contributions to regenerative medicine through his innovative patent demonstrate his commitment to advancing healthcare solutions. His work continues to inspire further research and development in tissue engineering.